Showing 61-70 of 327 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Modulation of beta cell mRNA Translation in Type 1 Diabetes | Beckman Research Institute of the City of Hope | Farooq Syed | Cures | 01-September-2024 to 31-March-2027 | $444.138,25 |
| Home-based oral glucose tolerance test for type 1 diabetes screening | Yale University | Alfonso Galderisi | Cures | 01-April-2025 to 31-March-2027 | $347.849,00 |
| Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics | University of Washington | Petter Bjornstad | Improving Lives | 01-June-2024 to 30-November-2025 | $488.511,63 |
| Eye biorepository: A hub for the restoring vision moonshot | Regents of the University of Michigan | Patrice Fort | Improving Lives | 01-March-2025 to 28-February-2026 | $218.095,83 |
| Role of oxidative post-translational modifications in generating neoepitopes | Weill Medical College of Cornell University | Laura Santambrogio | Cures | 01-April-2025 to 31-March-2028 | $600.000,00 |
| Program to Achieve FDA Agreement on Design of Confirmatory Trial for Verapamil | Kinexum LLC | Michael Zemel | Cures | 01-December-2024 to 30-June-2025 | $120.000,00 |
| T1D Adjunct Therapy Product & Patient Profiling Study | Magnolia Innovation, LLC | Kenneth Howie | Improving Lives | 01-December-2024 to 31-December-2025 | $434.000,00 |
| Combining Arteriovenous Bundle and ECM-Based Biomaterial Technologies to Induce Potent Neovascularization Following Islet Transplantation | Wake Forest University Health Sciences | Giuseppe Orlando | Cures | 01-April-2025 to 31-March-2026 | $248.692,00 |
| Single nucleus multiomics temporal profiling of islet immune cells in male and female NOD mice during UPR-deficiency-induced senescence | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Feyza Engin | Cures | 01-February-2025 to 31-January-2028 | $750.000,00 |
| ICAM-1 Knock Out Pluripotent Stem Cells for Hypoimmune Type 1 Diabetes Therapy | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Matthew Brown | Cures | 01-April-2025 to 31-March-2027 | $699.998,53 |